Table 5.
Outcomes of special types of invasive breast cancer who developed recurrence
| Patient no. | Type of infiltrative carcinoma | Adjuvant chemotherapy | First site(s) of recurrence | Time to recurrence (months) | Following site(s) of recurrence | Time to DFBC (months) |
|---|---|---|---|---|---|---|
| 1 | IMPC | CMF | CLBC | 14 | No | No |
| 2 | IMPC+IDC | CMF | Regional-nodal | 33 | Lung | 74 |
| 3 | IAC | CAF | Regional-nodal | 42 | No | No |
| 4 | IAC | CMF | Bone | 46 | Liver, regional-nodal | 68 |
| 5 | IPC | 0 | CLBC+regional-nodal | 30 | No | No |
| 6 | IPC | CMF | CLBC | 22 | No | No |
| 7 | IPC | CMF | Regional-nodal | 46 | No | No |
| 8 | IPC | 0 | Loco-relapse | 30 | No | No |
| 9 | IPC+IDC | CMF | Lung | 24 | Liver, bone | 50 |
| 10 | ICC | 0 | CLBC | 42 | NO | No |
| 11 | GRCC | CMF | Unknown | Unknown | Unknown | 80 |
| 12 | MC | CMF | Bone | 50 | No | No |
| 13 | MC+IDC | CMF | Lung | 54 | No | No |
| 14 | MC | CMF | Loco-relapse | 45 | No | No |
| 15 | MBC | CAF | Lung | 34 | Brain | 40 |
| 16 | ACC | CMF | Loco-relapse+regional-nodal | 46 | No | No |
| 17 | carcinosarcoma | CAF | Lung | 35 | No | No |
Abbreviations: IMPC, Invasive micropapillary carcinoma; IDC, invasive ductal carcinoma; IAC, Invasive apocrine carcinoma; IPC, Invasive papillary carcinoma; ICC, Invasive cribriform carcinoma; GRCC, Glycogen-rich clear cell carcinoma; MC, Mucoid carcinoma; MBC, Metaplastic breast cancer; ACC, adenoid cystic carcinoma; CMF, cyclophosphamide, methotrexate and fluorouracil; CAF, cyclophosphamide, doxorubicin and fluorouracil; CLBC, contralateral breast cancer; DFBC, death from breast cancer.